tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
Advertisement

Gland Pharma Ltd. (GLAND) Financial Statements

Compare
1 Followers

Gland Pharma Ltd. Financial Overview

Gland Pharma Ltd.'s market cap is currently ₹321.71B. The company's EPS TTM is ₹13.08; its P/E ratio is 41.77; and it has a dividend yield of 0.92%. Gland Pharma Ltd. is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is ₹13.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

Gland Pharma Ltd. Debt to Assets

Gland Pharma Ltd. Cash Flow

Gland Pharma Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis